Background: The volume-outcome relationship in surgery has been a focus of interest for over a decade. The National Institute for Health and Care Excellence (NICE) published their improving outcome guidance in 2002, which encouraged a regionalised multidisciplinary approach in managing urological cancer cases and recommended centralisation of urological pelvic surgery. The current study offers an updated view on the urological pelvic services in England with regard to radical cystectomy (RC) and radical prostatectomy (RP) and adherence to improving outcome guidance guidelines and patterns of services provision since its introduction in 2002. Methods: The data for inpatient elective RC and RP were taken from hospital episodes statistics for 2003-2013. The RC and RP cases were calculated separately per year for every trust to calculate the annual rates and then combined for every trust. The catchment areas for RC and RP were calculated using the proportionate-flow method. Results: The number of trusts performing RC and RP reduced significantly over the 10 years, while in the same period, the numbers of RC and RP performed increased significantly (P<0.05). There has been a steady increase in the cases referred to another trust for their RC or RP surgery (P<0.05). Overall, there has been a significant increase in the number of trusts achieving the improving outcome guidance recommended minimal case volume of 50 or more (RC + RP combined) over the 10-year analysis (P=0.0006). Conclusion: There has been a shift in urological pelvic surgery provision in England since the publication of improving outcome guidance by NICE in 2002, with over 95% of cases being performed in improving outcome guidance compliant centres achieving 50 cases or more per year. Simultaneously, a significant reduction in postoperative mortality and the hospital length of stay has been seen over this period.
Introduction
The volume-outcome relationship in surgery has been a focus of interest for over a decade and has been one of the areas of health services research that has translated to health policy reform. There is evidence that both supports and diminishes the effect of volume on quality of care, dependent on clinical considerations such as the procedure or outcome of choice, the unit of analysis (institution or surgeon) and methodological considerations of big data analysis including clustering and teasing out the interplay of structural, process and patient-related determinants. With respect to urological cancer services there is evidence to support higher volume better outcomes for radical cystectomy (RC) 1, 2 and radical prostatectomy (RP). [3] [4] [5] [6] [7] [8] [9] Recognising the importance of this relationship and in order to consolidate the services of these procedures the National Institute for Health and Care Excellence (NICE) published their improving outcome guidance (IOG) in 2002, 10 which encouraged a regionalised multidisciplinary approach in managing urological cancer cases and recommended centralisation of certain urological services. In 2011, this was peer-reviewed by the national cancer peer review and adopted as a strategy for cancer care in the UK to improve treatment for patients with prostate and bladder cancers. 11 The guidance recommends that a service should perform at least 50 pelvic surgeries (combined RC and RP) in total per year. It also recommended a minimum catchment population of 1 million to generate the above numbers. A report in 2009 showed signs of early changes to the urological pelvic services in the UK, with 34.2% of trusts adhering to the 50 cases per year. 12 The current study offers an updated view on the urological pelvic services in England with regard to RC and RP and adherence to IOG guidelines and patterns of service provision since its introduction in 2002.
Methods
The method for data extraction was similar to a previous report 12 for comparison, but in summary, data for inpatient elective RC (OPCS4 code M34) and RP (OPCS code M61) were taken from hospital episodes statistics for 2003-2013, to examine the pattern of service provision and outcomes in the 10 years following the publication of IOG guidelines.
Episodes were excluded if they had invalid age or sex or had no length of stay (LOS) or were recorded as a daycase or as an emergency. Cases were also excluded if there was no primary diagnosis of cancer (codes C66, C67, C68, D09.0, D41.4 for bladder or C61 for prostate).
The RC and RP cases were calculated separately per year for every trust to calculate the annual rates and then combined for every trust. Trusts were presented in similar volume bands to a previous report 12 for comparison. The catchment areas for RC and RP were calculated using the proportionate-flow method as described by the eastern region public health observatory. 13 For statistical analysis, we used chi-square for the categorical data and linear regression to measure the relationship between variables. P values of 0.05 or less were considered to be statistically significant.
Results
Over the 10-year analysis (2003-2013), 14,295 RC and 41,620 RP surgeries were performed giving a total of 55,915 cases. There has been an increase in the number of procedures performed annually since IOG was introduced, and in 2013 1404 radical cystectomies and 5480 radical prostatectomies were performed.
The number of trusts performing RC reduced significantly over the 10 years from 125 (2003) to 54 (2013) (P<0.0001), although the number of RC performed increased significantly from 967 cases to 1404 cases (P=0.0011). The number of low-volume trusts declined over the 10-year period, while the number of high volume centres increased ( Figure 1 ).
For RP, the number of trusts performing the procedure reduced significantly over the study period from 122 (2003) to 66 (2013) (P<0.0001). While in the same period, the number of RP performed increased significantly from 1911 to 5480 (P<0.0001). The low-volume RP trusts declined over the 10-year period while high volume centres increased in the same period ( Figure 2 ).
There has been a steady increase in the cases referred to another trust for their RC operation from 412 in 2003 to 556 in 2013 (P=0.0064). Similarly, there has been a significant increase in cases referred for their RP from 958 in 2003 to 2143 cases in 2013 (P=0.0415). Overall, there has been a significant increase in the number of trusts achieving the IOG recommended minimal case volume of 50 or more (RC and RP combined) over the 10-year analysis (P=0.0006, see Figure 3 ). In 2003, only nine out 136 trusts reached the 50 case threshold in which 554 cases (19.2% of the total) were performed. In 2013, 48 out of 69 trusts were IOG compliant, and less than 5% of cases were performed in non-IOG compliant centres (see Table 1 ). Many of the operating centres achieved IOG compliance based on either RP or RC numbers alone. In fact 44 centres performed 50 or more RP per year and five centres performed 50 or more RC per year.
In 2013, only one trust had a catchment population of 1 million or more. The median catchment population for the IOG compliant trusts was 507,289 (range 116,034 -874,742).
There has been a significant improvement in outcomes over the same 10-year period. The 30-day mortality following RC dropped by 45% to 1.3% in 2013 (P=0.0109) and the 90-day mortality dropped by 55% to 2.6% in 2013 (P=0.0015). The median LOS has dropped from 15 to 11 days (P<0.0001). For RP, the trend in change for mortality over the observed period is less clear-cut. Although the 30-day mortality has improved, this was not statistically significant (P=0.0820), while the 90-day mortality dropped by 80% to 0.1% in 2013 (P=0.01). The median hospital stay dropped from 4 to 2 days (P=0.0001, Table 1 ).
Discussion
The IOG recommendation published in 2002 was based on the growing evidence of the volume-outcome relationship in urology. [1] [2] [3] [4] [5] [6] [7] [8] [9] It had a positive effect on centralising pelvic urological surgery in the UK, and a previous review showed a trend towards centralisation, with 30% of trusts achieving the IOG recommended 50 case cut-off level in 2003. 12 We offer an updated review, covering 10 years following the introduction of the IOG guidelines. There has been a significant steady increase in high-volume centres for RC and RP, and in 2013 70% of operating trusts reached the 50 case cut-off, which accounted for 95% of the total RC and RP performed.
Previous reports on RP have shown that higher volume reduces late urinary complications 5 and increases recurrence-free survival 6 and reduces the need for additional treatment. 5 Our data demonstrated a trend towards reduction in postoperative mortality, which is likely to be related to a number of factors including operative technique, but also improvements in the preoperative planning and postoperative care. This is consistent with the reduction in LOS seen over time. For RC, the reduction in mortality and LOS were more evident and explainable by the relative complexity of the surgery and associated morbidities of the patient cohort, meaning that there are greater opportunities for margins of potential improvement. Despite the IOG recommendation of at least 1 million or more catchment population, only one trust reached this threshold in 2013. Although most compliant trusts had a catchment population of 0.5 million or more. Arguably, a catchment population figure does not take into account the local population age, local environmental or economic differences that might influence the disease. The fact that most IOG-compliant trusts had a catchment population of less than 1 million but were still reaching the 50 case cutoff could reflect the increasing yearly referrals into these tertiary centres.
Conclusion
There has been a shift in urological pelvic surgery provision in England since the publication of the IOG by NICE in 2002, with over 95% of cases being performed in IOGcompliant centres achieving 50 or more cases per year. Simultaneously, a reduction in postoperative mortality and the hospital LOS has been observed over this period.
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